Evidence map›Paper›PMID 39502486›Full record

ReviewDigital health

Progress and clinical translation in hepatocellular carcinoma of deep learning in hepatic vascular segmentation.

Tianyang Zhang, Feiyang Yang, Ping Zhang

Abstract readReview
In one paragraph

Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tianyang ZhangThe First Hospital of Jilin University, Changchun, Jilin, China.
Feiyang YangCollege of Computer Science and Technology, Jilin University, Changchun, China.
Ping ZhangThe First Hospital of Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0000-0003-4944-2937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper reviews the advancements in deep learning for hepatic vascular segmentation and its clinical implications in the holistic management of hepatocellular carcinoma (HCC). The key to the diagnosis and treatment of HCC lies in imaging examinations, with the challenge in liver surgery being the precise assessment of Hepatic vasculature. In this regard, deep learning methods, including convolutional neural networksamong various other approaches, have significantly improved accuracy and speed. The review synthesizes findings from 30 studies, covering aspects such as network architectures, applications, supervision techniques, evaluation metrics, and motivations. Furthermore, we also examine the challenges and future prospects of deep learning technologies in enhancing the comprehensive diagnosis and treatment of HCC, discussing anticipated breakthroughs that could transform patient management. By combining clinical needs with technological advancements, deep learning is expected to make greater breakthroughs in the field of hepatic vascular segmentation, thereby providing stronger support for the diagnosis and treatment of HCC.

Indexed as

clinical translationdeep learninghepatic vascular segmentationHepatocellular carcinoma

Identifiers

PMID39502486
PMCPMC11536605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.